|Year : 2015 | Volume
| Issue : 3 | Page : 83-88
Visceral adipose tissue influences on coronary artery calcification at young and middle-age groups using computed tomography angiography
Rami M Abazid1, M Obadah Kattea1, Sawsan Sayed2, Hanaa Saqqah3, Mohammed Qintar4, Osama A Smettei1
1 Department of Cardiology; Department of ardiac Imaging, Prince Sultan Cardiac Center Al-Qassim, Buraydah, Saudi Arabia
2 Department of Cardiology, Prince Sultan Cardiac Center Al-Qassim, Buraydah, Saudi Arabia
3 Department of Cardiac CT Technicians, Prince Sultan Cardiac Center Al-Qassim, Buraydah, Saudi Arabia
4 Department of Internal Medicine, Cleveland Clinic Foundation Cleveland, OH, Saudi Arabia
|Date of Web Publication||8-Jul-2015|
Rami M Abazid
Department of Cardiology, Prince Sultan Cardiac Center Al Qassim, Buraydah, Postal Code 2290
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Purpose: The purpose of the study was to evaluate the impact of excessive visceral adipose tissue (VAT) on subclinical coronary atherosclerosis and coronary artery calcifications (CAC) in young and middle-age groups using multislice computed tomography. Methods: This study is a single center, cross-sectional study. Eligible patients (n = 159), who under the age of 61 years, with chest pain and mild to moderate probability to have coronary artery disease (CAD) were enrolled. Coronary calcium score and epicardial adipose tissue (EAT) were measured at the level of the left main coronary artery while VAT was measured at the level of the iliac crest. Results: The average age was (48 ± 8 years). The mean VAT was (38 ± 21 cm 2 ) with no significant difference between men and women (38 ± 22 vs. 37 ± 19 P = 0.8) respectively. Student's t-test analysis showed significantly higher VAT in patients with detectable CAC than patients with no CAC (48 ± 24 vs. 33 ± 18 P = 0.00002), respectively. Univariate regression analysis showed that VAT and EAT, are strong predictor for CAC (hazard ratio [HR] 1.034, 95% confidence interval [CI: 1.016-1.052]. P <0.001 and [HR] 1.344, 95% CI: [1.129-1.601] P = 0.001), respectively. Conclusion: Excessive VAT is significantly associated with positive CAC. VAT can strongly predict subclinical CAD in individuals at young and middle-age groups.
Keywords: Computed tomography-angiography, coronary artery calcifications, visceral adipose tissue
|How to cite this article:|
Abazid RM, Kattea M O, Sayed S, Saqqah H, Qintar M, Smettei OA. Visceral adipose tissue influences on coronary artery calcification at young and middle-age groups using computed tomography angiography. Avicenna J Med 2015;5:83-8
|How to cite this URL:|
Abazid RM, Kattea M O, Sayed S, Saqqah H, Qintar M, Smettei OA. Visceral adipose tissue influences on coronary artery calcification at young and middle-age groups using computed tomography angiography. Avicenna J Med [serial online] 2015 [cited 2017 Mar 29];5:83-8. Available from: http://www.avicennajmed.com/text.asp?2015/5/3/83/160242
| Introduction|| |
Obesity is a well-recognized risk factor for coronary artery disease (CAD).  Higher mortality was observed in both sexes older than age 50 in all racial and ethnic groups with increased body mass index (BMI).  Furthermore, adiposity has a causative effect on other risk factors of CAD including diabetes mellitus (DM), hypertension (HTN), and metabolic syndrome. , Metabolic syndrome is independently associated with CAD extension and poor outcome as well in patients with acute coronary syndrome.  Waist circumference, which is used as one of the diagnostic criteria for metabolic syndrome,  may reflect the effect of body fat accumulation on cardiac events and mortality better than BMI. , At older ages, excessive visceral adipose tissue (VAT) measured by computed tomography angiography (CTA) is an independent predictor of CAD severity, coronary artery calcifications (CAC), and may contribute to the atherosclerosis extension. , However, there are Limited data on the relationship between VAT and CAD in young and middle-age patients. We hypothesized that increased VAT accumulation is associated with increased CAC score and hence subclinical CAD in young and middle age individuals.
| Methods|| |
In this cross-sectional study, we enrolled a total of 159 patients between March 13, 2013 and July 28, 2014, all of them underwent multi-slice computed tomography. Eligible patients were under the age of 61 years, presented with chest pain with mild to moderate pretest probability for CAD and were referred for coronary CTA due to chest pain. All patients older than 60 years, had past history of coronary revascularization, and patients with a high probability of CAD were excluded. Coronary calcium score (CCS) and epicardial adipose tissue (EAT) were measured at the level of left main (LM) coronary artery while VAT was measured at the level of the iliac crest.
Patients' demographics, medical and surgical history were obtained from the medical records. Data collected included age, sex, race, smoking history, drug history, past history, family history of CAD, DM, HTN, dyslipidemia, patient's weight and height. Patient's weight, height, waist and hip circumference and waist-hip ratio (WHR) were measured, and BMI was calculated. We reported the traditional risk factors for CAD including DM, HTN, smoking, family history of premature CAD, and hyper/dyslipidemia. CCS and EAT were measured at the level of LM coronary artery while VAT was measured at the level of the iliac crest. Informed written consent was obtained from all included patients. The study was approved by our center research ethics committee.
Calcium score acquisition
Imaging was performed using dual-source CT scanner (Definition Flash; Siemens Healthcare, Forchheim, Germany; 280-ms rotation, 2_128_0.6 mm collimation) in deep inspiration. The scan begins with a scout imaging of the entire chest and abdomen, to define the view fields of coronary calcium and then for VAT acquisitions. The former acquired by prospective electrocardiogram-triggering scan with (3 mm slice thickness tube current 35 mA) then the raw data Reconstruction using Multi-Modality Workplace (SyngoMMWP VE40A, Siemens Medical Solutions, Forchheim, Germany) and calcium score software (VE40A) to calculate coronary calcium using Agatston method.
Adipose visceral tissue calculation
Nongated abdominal scan with 3 mm slice thickness was done at the level of the iliac crest to analyze VAT. Manual tracing of intraperitoneal fat at single slice used to calculate visceral fat volume using SyngoMMWP workstation, volume software (VE40A), and set the attenuation values within a range of −190 to −50 hounsfield units to define fat. We measured subcutaneous adipose tissue (SAT) volume by tracing extraperitoneal fat area [Figure 1]a.
|Figure 1: (a) Visceral adipose tissue measurement by manually tracing the intraperitoneal adipose area at the level of the iliac crest. (b) Epicardial adipose tissue measurements by tracing the epicardial area at the level of the left main coronary artery. VAT: Visceral adipose tissue; EAT: Epicardial adipose tissue; LM: Left main coronary artery|
Click here to view
Epicedial adipose tissue
Using calcium score data to select a 3 mm slice at the level LM coronary artery then manual tracing of epicardial fat tissue to estimate the EAT applying the same parameter of fat definition used for analyzing VAT with SyngoMMWP workstation and volume software (VE40A), [Figure 1]b.
Computed tomography angiography data
Coronary stenosis was graded by quantitative measurements using SyngoMMWP workstation into four categories: Normal if no stenosis, mild (>0-30% stenosis), moderate (31-70% stenosis), and severe (>70%).
Clinical characteristics were presented as a percentage (%) for categorical variables, mean ± standard deviation for normally distributed continuous variables and median (interquartile range) for nonnormally distributed continuous variables. For normally distributed continuous variables two-sample t-test were performed, and Wilcoxon rank-sum tests were used for nonnormally distributed continuous variables; Chi-square or Fisher's exact tests were run for categorical variables. Multivariable logistic regression models were used to assess the association between VAT and CAC in middle and young age group. All baseline characteristics were considered for inclusion into the model. A P < 0.05 was considered statistically significant for all tests. All statistical analyses were performed using SPSS for Windows (Version 19.0 SPSS Inc., Chicago, IL, USA).
| Results|| |
[Table 1] shows the clinical characteristics of cohort subjects. A total of 159 patients with a mean age of 48 ± 8 years and mean BMI (30.5 ± 5.6), with women having higher BMI than men (31.8 ± 5.4 vs. 29.8 ± 5.6, P = 0.03), respectively. The prevalence of overweight and obese patients with BMI > 25 is (132/159, 83%) while 5% are morbidly obese and have BMI > 40.
|Table 1: Patients baseline clinical characteristics and comparison between patients with no coronary calcium (group A), and patients with detectable coronary calcium (group B)|
Click here to view
Coronary artery calcifications score analysis
Coronary calcium detected in 49 patients (31%), with higher prevalence in men (36%) than in women (21%). The average CCS is (39 ± 153).
Association between the coronary calcification (CAC) and VAT: Patients were divided into two groups according to the CAC: Group (A) with no calcification and group (B) with detectable CAC. The result of Student's t-test analysis comparing group A and B showed that VAT and EAT are significantly higher in group B than in group A, (48 ± 24 vs. 33 ± 18 P = 0.00002) for VAT and (4.7 ± 2.6 vs. 3.4 ± 1.7 P = 0.0002) for EAT, respectively, with no significant difference in SAT (57 ± 38 vs. 58 ± 35, P = 0.22), respectively. Patients in group B were older in age (52 ± 6 vs. 46 ± 9 P < 0.0001,) and had significantly higher prevalence of Diabetes (26/49 [53%] vs. 29/110 [27%]) and smoking (27% vs. 14%) (P = 0. 002). Other parameters did not show a significant difference, [Table 1].
Univariate logistic regression analysis showed that VAT, EAT, age, DM, and dyslipidemia are strong predictor for CAC. Family history, smoking, HTN and Male sex showed a strong trend towards significance for predicting CAC [Table 2]a.
|Table 2: (A) Univariate logistic regression for variables associated with CAC shows that VAT, EAT, Age, DM and Dyslipidemia are strong predictors for CAC. (B) multivariate logistic regression for variables associated with CAC. (C) Multivariate logistic regression for variables associated with CAC when VAT is not put in the model|
Click here to view
Multivariate logistic regression analysis was done while controlling for important clinical variables including the following: Age, Sex, BMI, DM, HTN, dyslipidemia, family history, smoking, VAT, EAT, and WHR showed that VAT is the strongest independent predictor of CAC in the model (hazard ratio [HR] = 1.034, 95% confidence interval [CI: 1.013-1.055] P = 0.001). When VAT is not controlled for in the multivariate logistic model, EAT is an independent predictor of CAC (HR = 1.277, 95% CI: [1.055-1.571] P = 0.013), [Table 2]b and c.
Student's t-test analysis of subset groups showed that VAT is significantly higher in patients with CAC than in patients without CAC (50 ± 23 vs. 32 ± 18, P < 0.0001) for men but not significant in women (44 ± 26 vs. 35 ± 17 P = 0.1), respectively, [Table 3], [Figure 2]A and B.
|Table 3: Subset analysis of men vs. women showed more association between VAT and CAC in men|
Click here to view
Computed tomography angiography data analysis
All patients underwent CTA except two patients due to very high CAC score. Patients with detectable calcium have significantly higher prevalence of coronary stenosis, [Figure 3].
|Figure 3: Coronary angiographic data showed significantly higher grade of stenosis in the presence of calcium. Mild (>0-30%), moderate (31-70%), and severe stenosis (>70%)|
Click here to view
| Discussion|| |
Obesity is a well-established independent risk factor for cardiovascular disease.  Obese men and women are at increased risk of CAD.  The reported all-cause mortality is higher in white adults with BMI of >25,  however, abdominal adipose tissue distribution measured by WHR found to predict cardiovascular sequelae, stroke, and death better than BMI. ,
Subcutaneous fat are less pathogenic than visceral fat accumulation, as the latter considered metabolically more active tissue that contributes to higher adipocyte dysfunction.  This results in hypersecretion of adipocytokines such as interleukin-6, tumor-necrosis factor-alpha, and plasminogen activator inhibitor type-1 with decrease secretion of adiponectin. ,,, The net effect of these abnormalities leads to metabolic changes that play a major role in increase insulin resistance, DM, metabolic syndrome, and atherosclerosis with adiposity. 
Multidetector CT (MDCT) is an important tool for quantification of abdominal fat distribution and can accurately distinguish VAT from Subcutaneous fat.  Furthermore, MDCT with a low radiation dose can reliably assess the extent and number of CAC.  The severity of calcifications is expressed as numbers using different scoring methods such as Agatston scoring that is most widely used. 
Detection of CAC at one or more of the coronary arteries confirm the presence of atherosclerotic cardiovascular disease (ASCVD), and the existence of calcium as a part of atheroma composition places the plaque under the definition of advanced types of atherosclerotic lesions.  CAC can provide a sensible estimation of the total coronary atheroma including noncalcified plaque (NCP) burden.  The extent of calcifications has an independent prognostic value in long-term follow-up for the prediction of cardiovascular death, myocardial infarction and provides more accurate prediction of all-cause mortality than standard CAD risk factors. ,,,
Our cross-sectional study results demonstrated that the presence of CAC is significantly associated with higher VAT volume in patients with CAC than in patients without. The age of our patients is between 25 and 60 years old. Furthermore, we found that VAT has a stronger association with CAC than the other traditional risk factors of CAD.
Many studies investigated the relationship between VAT and CAD. Our results are consistent with those of previous reports. Marques et al.  which showed that visceral fat area (VFA), determined at different intervertebral levels, were significantly related to CAD with odds ratio of 2.85 when VFA is >145 cm 2 at the intervertebral level T12-L1, while other anthropometric adiposity measurements (BMI, waist and hip circumferences) had no significant association. In addition, Imai et al.  found VFA positively associated with progressing of NCP burden but not with calcified plaque after 38 months follow-up. Ohashi et al.  reported that NCP burden and features of vulnerable plaque are significantly associated with higher VAT area. Another report by Ohashi et al.  found VAT is significantly associated with the extent of CAC. These reports support the role of excessive adipose tissue distribution on increase prevalence of CAD. We suggest further studies in the same age group that calculate total abdominal VAT volume with including NCP extension and severity. Inability to follow-up by MDCT to see the effect of excess VAT on the progression of CAC was a limitation to our study. Furthermore, we did not study the association of VAT with NCP, which may provide better idea about the severity of ASCVD at early stages of plaque formation. Our study is a cross-sectional analysis of VAT that is less accurate and more variable than volumetric assessment and finally, we excluded patients with a high probability of having CAD.
| Conclusion|| |
Young and middle age group of patients with detectable CAC tend to have a higher VAT than patients with no CAC. VAT can strongly predict subclinical CAD, mainly in men. Further studies to investigate the effect of VAT on the development of ASCVD at younger age group are required.
| References|| |
Hotchkiss JW, Davies CA, Leyland AH. Adiposity has differing associations with incident coronary heart disease and mortality in the Scottish population: Cross-sectional surveys with follow-up. Int J Obes (Lond) 2013;37:732-9.
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al.
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-78.
Mann GV. The influence of obesity on health (second of two parts). N Engl J Med 1974;291:226-32.
Van Itallie TB. Obesity: Adverse effects on health and longevity. Am J Clin Nutr 1979;32 12 Suppl: 2723-33.
Birhan Yilmaz M, Guray U, Guray Y, Altay H, Demirkan B, Caldir V, et al.
Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes. Coron Artery Dis 2005;16:287-92.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.
Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
Hotchkiss JW, Leyland AH. The relationship between body size and mortality in the linked Scottish Health Surveys: Cross-sectional surveys with follow-up. Int J Obes (Lond) 2011;35:838-51.
Staiano AE, Reeder BA, Elliott S, Joffres MR, Pahwa P, Kirkland SA, et al.
Body mass index versus waist circumference as predictors of mortality in Canadian adults. Int J Obes (Lond) 2012;36:1450-4.
Ohashi N, Yamamoto H, Horiguchi J, Kitagawa T, Kunita E, Utsunomiya H, et al.
Association between visceral adipose tissue area and coronary plaque morphology assessed by CT angiography. JACC Cardiovasc Imaging 2010;3:908-17.
Ohashi N, Yamamoto H, Horiguchi J, Kitagawa T, Hirai N, Ito K, et al.
Visceral fat accumulation as a predictor of coronary artery calcium as assessed by multislice computed tomography in Japanese patients. Atherosclerosis 2009;202:192-9.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
Wilson PW, D′Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 2002;162:1867-72.
Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al.
Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363:2211-9.
Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984;289:1257-61.
Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984;288:1401-4.
Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al
. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48.
Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K. Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 1998;41:860-1.
Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000;67:291-300.
Festa A, D′Agostino R Jr, Tracy RP, Haffner SM, Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes 2002;51:1131-7.
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al.
Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
Matsuzawa Y. Therapy Insight: Adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;3:35-42.
Sjöström L, Kvist H, Cederblad A, Tylén U. Determination of total adipose tissue and body fat in women by computed tomography, 40K, and tritium. Am J Physiol 1986;250:E736-45.
Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, et al.
Assessment of coronary artery disease by cardiac computed tomography: A scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006;114:1761-91.
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al.
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512-31.
Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, et al.
Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation 1996;94:1175-92.
Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al.
Long-term prognosis associated with coronary calcification: Observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-70.
Williams M, Shaw LJ, Raggi P, Morris D, Vaccarino V, Liu ST, et al.
Prognostic value of number and site of calcified coronary lesions compared with the total score. JACC Cardiovasc Imaging 2008;1:61-9.
Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis Heart Study. J Am Coll Cardiol 2005;46:158-65.
Marques MD, Santos RD, Parga JR, Rocha-Filho JA, Quaglia LA, Miname MH, et al.
Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography. Atherosclerosis 2010;209:481-6.
Imai A, Komatsu S, Ohara T, Kamata T, Yoshida J, Miyaji K, et al.
Visceral abdominal fat accumulation predicts the progression of noncalcified coronary plaque. Atherosclerosis 2012;222:524-9.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]